3/18
03:08 pm
nspr
InspireMD Inc (NSPR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advancements [Yahoo! Finance]
Low
Report
InspireMD Inc (NSPR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advancements [Yahoo! Finance]
3/18
12:37 pm
nspr
InspireMD, Inc. (NSPR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
InspireMD, Inc. (NSPR) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/18
12:36 pm
nspr
InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains U.S. traction [Seeking Alpha]
Low
Report
InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains U.S. traction [Seeking Alpha]
3/18
07:40 am
nspr
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
High
Report
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/18
07:00 am
nspr
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results
3/9
09:04 am
nspr
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/9
09:00 am
nspr
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
Low
Report
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
2/24
11:05 am
nspr
InspireMD (NYSE:NSPR) was given a new $5.00 price target on by analysts at Loop Capital.
Medium
Report
InspireMD (NYSE:NSPR) was given a new $5.00 price target on by analysts at Loop Capital.
2/24
10:04 am
nspr
InspireMD (NYSE:NSPR) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
Medium
Report
InspireMD (NYSE:NSPR) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
2/2
08:00 am
nspr
InspireMD (NYSE:NSPR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
Low
Report
InspireMD (NYSE:NSPR) is now covered by analysts at Maxim Group. They set a "buy" rating and a $6.00 price target on the stock.
1/20
09:00 am
nspr
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/12
09:00 am
nspr
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
Medium
Report
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
1/10
07:02 pm
nspr
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago [Yahoo! Finance]
Medium
Report
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago [Yahoo! Finance]